2012 News

November 11, 2012

FDA Grants Orphan Drug Status to Morphotek's Amatuximab (MORAb-009)
Read More

August 26, 2012

Morphotek, Inc. Announce Initiation of MORAb-004 Phase II Study in Metastatic Soft Tissue Sarcoma
Read More

August 14, 2012

Morphotek, Inc. Opens 60,000-Square-Foot Manufacturing Plant
Read More

May 30, 2012

Morphotek Earns Prestigious Award for Innovation in Assay Development
Read More

May 11, 2012

Morphotek, Inc. Participates in the Fourth Annual Philadelphia Ronald McDonald House Plane Pull
Read More

April 16, 2012

Morphotek, Inc. Announces Initiation of MORAb-004 Phase 2 Study in Metastatic Colorectal Cancer
Read More

March 27, 2012

Morphotek, Inc. Announces Completion of Enrollment in The FAR-131 Trial For Relapsed Ovarian Cancer
Read More

March 20, 2012

Biocare Medical Launches Key Diagnostic Kit to Identify Folate Receptor Alpha Expression
Read More

January 9, 2012

Morphotek Enters Into Agreements With Fox Chase Cancer Center to Acquire Clinical Samples for the Development and Validation of Companion Diagnostic Kits
Read More

News & Events > News Archive > 2012 News